Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer

touchMDT for touchONCOLOLOGY

Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes

The multidisciplinary team 

• Pathologist: Dr Peter Sadow, USA
• Endocrinologist: Dr Antonio Matrone, Italy
• Oncologist: Dr Lori Wirth, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//